天臣医疗:9月12日召开董事会会议

Group 1 - The core point of the article is that Tianchen Medical (SH 688013) held its 29th meeting of the second board of directors on September 12, 2025, to discuss a proposal for applying for a comprehensive credit line from banks [1] - For the fiscal year 2024, Tianchen Medical's revenue composition is 99.99% from medical devices and 0.01% from other businesses [1] - As of the report, Tianchen Medical has a market capitalization of 5.5 billion yuan [1]